Clinical Trials Browser

Phase 2 × Uterine Cervical Neoplasms × Hepatitis B Vaccines × Clear all

NCT01356823 2016-01-05

Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine

Phase 2 Completed

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms